WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011012901) METHOD FOR DETECTION OF, OR THE RISK OF, BLADDER CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/012901    International Application No.:    PCT/GB2010/051255
Publication Date: 03.02.2011 International Filing Date: 29.07.2010
IPC:
G01N 33/574 (2006.01)
Applicants: RANDOX LABORATORIES LTD [GB/GB]; Ardmore Diamond Road Crumlin, Co Antrim Northern Ireland Antrim BT29 4QY (GB) (For All Designated States Except US).
RUDDOCK, Mark, W. [GB/GB]; (GB) (For US Only).
REID, Cherith, N. [GB/GB]; (GB) (For US Only).
WILLIAMSON, Kathleen [GB/GB]; (GB) (For US Only).
LAMONT, John, V. [GB/GB]; (GB) (For US Only).
FITZGERALD, Stephen, P [GB/GB]; (GB) (For US Only)
Inventors: RUDDOCK, Mark, W.; (GB).
REID, Cherith, N.; (GB).
WILLIAMSON, Kathleen; (GB).
LAMONT, John, V.; (GB).
FITZGERALD, Stephen, P; (GB)
Agent: GILL JENNINGS & EVERY LLP; The Broadgate Tower 20 Primrose Street London EC2A 2ES (GB)
Priority Data:
0913249.9 29.07.2009 GB
0916193.6 15.09.2009 GB
Title (EN) METHOD FOR DETECTION OF, OR THE RISK OF, BLADDER CANCER
(FR) MÉTHODE DE DÉTECTION D'UN CANCER DE LA VESSIE, OU D'UN RISQUE DE CANCER DE LA VESSIE
Abstract: front page image
(EN)The present invention provides a method for the detection of, or the risk of, bladder cancer in a patient, comprising the step of detecting the presence of a combination of at least two biomarkers selected from CEA, VEGF, IL-8, NGAL, NSE, IL-2, EGF, TM, d-Dimer, MMP-9, IL-6, IL-4, MMP-9/NGAL, FAS, CRP, TUP and NMP22 in one or more samples isolated from a patient wherein the presence of a combination of at least two biomarkers in the one or more samples indicates the presence or risk of bladder cancer.
(FR)La présente invention concerne une méthode de détection d'un cancer de la vessie, ou d'un risque de cancer de la vessie, chez un patient, comprenant l'étape consistant à détecter la présence d'une combinaison d'au moins deux biomarqueurs sélectionnés parmi CEA, VEGF, IL-8, NGAL, NSE, IL-2, EGF, TM, D-dimère, MMP-9, IL-6, IL-4, MMP-9/NGAL, FAS, CRP, TUP et NMP22 dans un ou plusieurs échantillon(s) isolé(s) d'un patient, la présence d'une combinaison d'au moins deux biomarqueurs dans le ou les échantillons indiquant la présence ou le risque d'un cancer de la vessie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)